Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypertension

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    March 2017
  1. PETTINGER WA
    Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension.
    J Cardiovasc Pharmacol. 2017;69:129-139.
    PubMed     Text format     Abstract available


  2. JACKSON EK
    Editorial for "Hypertension's 3 Dilemmas & 3 Solutions: Pharmacology of the Kidney in Hypertension".
    J Cardiovasc Pharmacol. 2017;69:127-128.
    PubMed     Text format    


    October 2016
  3. CAMPOS C, Luz de Castro A, Vicente Tavares AM, Fernandes RO, et al
    Effect of free and nanoencapsulated copaiba oil on monocrotaline-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    July 2016

  4. Morphological Identification of TRPC7 in Cardiomyocytes from Normal and Renovascular Hypertensive Rats: Retraction.
    J Cardiovasc Pharmacol. 2016;68:96.
    PubMed     Text format    


    April 2016
  5. LIU X, Duan P, Hu X, Li R, et al
    Altered KATP channel subunits expression and vascular reactivity in spontaneously hypertensive rats with age.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  6. DEMIR M, Gurol AO, Ozyigit RT, Uresin AY, et al
    Effects of Blood Pressure Lowering with Different Antihypertensive Agents on Cognitive Function and Plasma Brain-Derived Neurotrophic Factor Levels: A Comparative Study.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  7. FARES WH
    Pushing the Envelope on the Indications and Doses of Pulmonary Arterial Hypertension Medications: What's Reasonable?
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format    


    January 2016
  8. PARIKH KS, Rajagopal S, Fortin T, Tapson VF, et al
    Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  9. LI Y, Geng X, Wang H, Cheng G, et al
    CTRP9 ameliorates pulmonary-arterial hypertension through attenuating inflammation and improving endothelial cell survival and function.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  10. VIRDIS A, Taddei S
    Endothelial Dysfunction In Resistance Arteries Of Hypertensive Humans: Old And New Conspirators.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  11. AKAGI S, Nakamura K, Matsubara H, Kondo M, et al
    Intratracheal administration of prostacyclin analog-incorporated nanoparticles ameliorates the development of monocrotaline and sugen/hypoxia-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  12. SHANG P, He ZY, Chen JF, Huang SY, et al
    Absence of the Adenosine A2A Receptor Confers Pulmonary Arterial Hypertension Through RhoA/ROCK Signaling Pathway in Mice.
    J Cardiovasc Pharmacol. 2015;66:569-75.
    PubMed     Text format     Abstract available


    November 2015
  13. MARTINEZ-AGUILAR L, Lezama-Martinez D, Orozco-Cortes NV, Gonzalez-Espinosa C, et al
    Antihypertensive properties of a the novel morphologic derivative (4-tert-buthyl-2,6-bis (thiomorpholine-4-ilmethyl)phenol).
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  14. LINZ B, Hohl M, Reil JC, Bohm M, et al
    Inhibition of NHE3-mediated sodium absorption in the gut reduced cardiac end-organ damage without deteriorating renal function in obese spontaneously hypertensive rats.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  15. ZHENG Y, Ma H, Hu E, Huang Z, et al
    Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    J Cardiovasc Pharmacol. 2015;66:504-14.
    PubMed     Text format     Abstract available


    October 2015
  16. FANG X, Chen X, Zhong G, Chen Q, et al
    Mitofusin 2 downregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PI3K/Akt and mitochondrial apoptosis pathways.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  17. LI MX, Jiang DQ, Wang Y, Chen QZ, et al
    Signal mechanisms of vascular remodeling in the development of pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  18. CUI LB, Li BW, Liang C, Dong Z, et al
    Morphological Identification of TRPC7 in Cardiomyocytes from Normal and Renovascular Hypertensive Rats.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  19. ZHANG X, Meng F, Song J, Zhang L, et al
    Pentoxifylline Ameliorates Cardiac Fibrosis, Pathological Hypertrophy and Cardiac Dysfunction in Angiotensin II-induced Hypertensive Rats.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  20. IKEDA T, Iwanaga Y, Watanabe H, Morooka H, et al
    The Effects of Long-Term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  21. GE B, Peng W, Zhang Y, Wen Y, et al
    Effectiveness of valsartan/amlodipine single-pill combination in hypertensive patients with excess body weight: Sub-analysis of CHINA STATUS II.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  22. MONTO F, Oliver E, Vicente D, Buendia F, et al
    beta2- AND beta1-ADRENOCEPTOR EXPRESSION EXHIBIT A COMMON REGULATORY PATTERN WITH GRK2 AND GRK5 IN HUMAN AND ANIMAL MODELS OF CARDIOVASCULAR DISEASES.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  23. IGLARZ M, Landskroner K, Bauer Y, Vercauteren M, et al
    Comparison of macitentan and bosentan on right ventricular remodeling in a rat model of non-vasoreactive pulmonary hypertension.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  24. WANG K, Ma J, Pang Y, Lao J, et al
    Niflumic acid attenuated pulmonary artery tone and vascular structural remodeling of pulmonary arterial hypertension induced by high pulmonary blood flow in vivo.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  25. LI HB, Qin DN, Suo YP, Guo J, et al
    Blockade of salusin beta in hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy in salt-induced hypertensive rats.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    September 2014
  26. AL DARAZI F, Zhao W, Zhao T, Sun Y, et al
    Small dedifferentiated cardiomyocytes bordering on microdomains of fibrosis: evidence for reverse remodeling with assisted recovery.
    J Cardiovasc Pharmacol. 2014;64:237-46.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: